Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(38%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_2
2
25%
Ph phase_1
1
13%
Ph not_applicable
5
63%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(4)
Other(1)

Detailed Status

Completed4
Recruiting2
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (12.5%)
Phase 22 (25.0%)
N/A5 (62.5%)

Trials by Status

completed450%
recruiting225%
unknown113%
active_not_recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8